Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
11/16/2006 | US20060259993 Amidases, nucleic acids encoding them and methods for making and using them |
11/16/2006 | US20060259988 Use of dg931 protein for treating diabetes, obesity and metabolic syndrome |
11/16/2006 | US20060259987 Variants of antithrombin III |
11/16/2006 | US20060258856 Method of isolating nucleic acids from stool samples |
11/16/2006 | US20060258855 High resolution analysis of genetic variation within cryptosporidium parvum |
11/16/2006 | US20060258850 Method for preparing human serum albumin through heat-treatment in the presence of divalent cation |
11/16/2006 | US20060258840 Peroxisome proliferator-activated receptor |
11/16/2006 | US20060258615 Administering to a mammal P1,P4-di(uridine 5'-)tetraphosphate, tetralithium salt; or P1,P4-di(uridine 5'-)tetraphosphate, tetrapotassium salt; in a pharmaceutically acceptable carrier to treat dry eye or retinal detachment |
11/16/2006 | US20060258611 Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference |
11/16/2006 | US20060258610 Modulation of STAT 6 expression for the treatment of airway hyperresponsiveness |
11/16/2006 | US20060258607 Ghrelin binding nucleic acids |
11/16/2006 | US20060258606 Transforming growth factor-beta response element decoys and methods |
11/16/2006 | US20060258596 Antimicrobial agents |
11/16/2006 | US20060258593 Methods and compositions for the treatment of gastrointestinal disorders |
11/16/2006 | US20060258576 Gdnf-related neuropeptides |
11/16/2006 | US20060258574 Novel compositions and methods for the treatment of psoriasis |
11/16/2006 | US20060258563 Nitrogen Oxide scavenging ability; digesting cytochrome c with restriction enzyme; use in prophylactic and therapeutics, measuring/treating nitrogen oxide concentrations in air, exhaust gas or water |
11/16/2006 | US20060258554 Bgl6 beta-glucosidase and nucleic acids encoding the same |
11/16/2006 | US20060257990 Carbonic anhydrase having increased stability under high temperature conditions |
11/16/2006 | US20060257989 Truncated aggrecanase molecules |
11/16/2006 | US20060257975 Encoded by nucleic acid of given sequence; hybridizes to complement of nucleic acid; use as molecular weight markers, |
11/16/2006 | US20060257974 Vaccinia virus vector comprising a nucleic acid encoding a fusion protein amino acid sequence consisting of Vif, Vpr, Vpu, Vpx, Rev, Tat, and Nef; genetic vaccines for treating viral diseases |
11/16/2006 | US20060257971 Antibodies to pro1561 polypeptide |
11/16/2006 | US20060257970 Human HAC3 |
11/16/2006 | US20060257965 Extracellular matrix signalling molecules |
11/16/2006 | US20060257959 Glucose dehydrogenase |
11/16/2006 | US20060257947 Thrombospondin fragments and uses thereof in clinical assays for cancer and generation of antibdies and other binding agents |
11/16/2006 | US20060257928 ANGE gene in atopy |
11/16/2006 | US20060257921 Novel nucleic acid molecules and polypeptides encoding baboon TAFI |
11/16/2006 | US20060257918 Polynucleotide encoding a novel human G-protein coupled receptor variant of the relaxin receptor HGPRBMY5v1, and variants thereof |
11/16/2006 | US20060257917 Fluorescent dyes, energy transfer couples and methods |
11/16/2006 | US20060257913 Genetic polymorphisms associated with myocardial infarction and uses thereof |
11/16/2006 | US20060257912 Methods and sequences to suppress primate huntington gene expression |
11/16/2006 | US20060257911 Of given nucleotide sequence; diagnosis, treatment, and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, and metabolic disorders |
11/16/2006 | US20060257906 Compositions comprising a library of analytes for detection, quantification and analyses |
11/16/2006 | US20060257904 Agglomeration protein cascades, compositions and methods regarding the same |
11/16/2006 | US20060257897 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
11/16/2006 | US20060257896 Splice variants, polynucleotide biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer |
11/16/2006 | US20060257894 Molecular typing of listeria monocytogenes, hybridization supports and kits for said molecular typing |
11/16/2006 | US20060257882 Novel polynuceotides and polypeptides encoded thereby |
11/16/2006 | US20060257881 Oligonucleotides for detecting male infertility |
11/16/2006 | US20060257880 Gastric and prostate cancer associated antigens |
11/16/2006 | US20060257868 Tissue specific genes and gene clusters |
11/16/2006 | US20060257867 Ghrelin binding nucleic acids |
11/16/2006 | US20060257864 Primers designed on basis of the difference of sequences among staphylococcal enterotoxin subtypes |
11/16/2006 | US20060257860 Compositions and assays to detect influenza virus A and B nucleic acids |
11/16/2006 | US20060257857 Methods for identifying functionally related genes and drug targets |
11/16/2006 | US20060257856 Heterodimeric receptor libraries using phagemids |
11/16/2006 | US20060257852 Severe acute respiratory syndrome coronavirus |
11/16/2006 | US20060257851 Bioinformatically detectable group of novel viral regulatory genes and uses thereof |
11/16/2006 | US20060257500 TRPC6 involved in glomerulonephritis |
11/16/2006 | US20060257421 Pneumolysin derivatives |
11/16/2006 | US20060257409 Breast Specific Genes and Proteins |
11/16/2006 | US20060257407 Anti-IL-6 antibodies, compositions, methods and uses |
11/16/2006 | US20060257406 Immunoglobulin variable domain; tumor necrosis factor; competitve binding; surface plasmon resonance |
11/16/2006 | US20060257399 Mixture comprising n-glycan modified antibodies exhibiting increased antibody-dependent cellular cytoxicity (ADCC); targeted destruction of tumor cells |
11/16/2006 | US20060257387 Sugar chain synthase gene |
11/16/2006 | US20060257367 Tumour-cell specific gene expression and its use in cancer therapy |
11/16/2006 | DE102006020872A1 Verfahren zur Nucleinsäureisolierung und Vorrichtung zur Nucleinsäureisolierung A method for nucleic acid isolation and apparatus for nucleic acid isolation |
11/16/2006 | DE102005023055A1 Making DNA fragments for determining DNA methylation pattern involves digesting DNA with methylation-specific restriction enzyme; and ligating adapters to restriction fragments, followed by primer mediated-amplification of ligated fragments |
11/16/2006 | DE10010282B4 Verfahren zur Detektion von Cytosin-Methylierung in DNA Proben Process for detection of cytosine methylation in DNA samples |
11/16/2006 | CA2651376A1 Method for diagnosis and treatment of a mental disease |
11/16/2006 | CA2607330A1 Plants containing a heterologous flavohemoglobin gene and methods of use thereof |
11/16/2006 | CA2605015A1 Compositions and assays to detect influenza virus a and b nucleic acids |
11/15/2006 | EP1721908A1 Novel method of synthesizing nucleic acid without protecting nucleotide bases |
11/15/2006 | EP1721907A1 Silyl linker for solid-phase synthesis of nucleic acid |
11/15/2006 | EP1721257A2 Differential expression of markers in ovarian cancer |
11/15/2006 | EP1720990A2 High efficiency peptide production in plant cells |
11/15/2006 | EP1720892A2 Branched polymeric sugars and nucleotides thereof |
11/15/2006 | EP1720539A2 Schizochytrium fatty acid synthase (fas) and products and methods related thereto |
11/15/2006 | EP1008351B1 Carcinostatic agents |
11/15/2006 | EP0543942B2 Homogeneous assay system |
11/15/2006 | CN1863928A Diagnostic and therapeutics for osteoporosis |
11/15/2006 | CN1863923A Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases |
11/15/2006 | CN1863915A Lambda integrase mediated recombination in plants |
11/15/2006 | CN1863818A Anti-VEGF antibodies |
11/15/2006 | CN1863552A Tyrosinase mutant and methods of use thereof |
11/15/2006 | CN1861800A Macroporous support for chemical amplification reactions |
11/15/2006 | CN1861795A Product and process for transformation of thraustochytriales microorganisms |
11/15/2006 | CN1284795C Magnetic nano particle nucleic acid separator, and its preparing method and use |
11/14/2006 | US7135622 Mevalonate synthesis enzymes |
11/14/2006 | US7135614 Brassica or helianthus plants having mutant delta-12 or delta-15 sequences |
11/14/2006 | US7135613 Zebrafish emit green fluorescence under blue or ultraviolet light according to specificity of promoters in germ or somatic cells; capable of breeding to produce viable and fertile progeny |
11/14/2006 | US7135611 Animal models for use in identifying modulators for treatment of obesity |
11/14/2006 | US7135565 Synthesis of polynucleotides using combined oxidation/deprotection chemistry |
11/14/2006 | US7135564 Reacting a linker arm cleaving the oligonucleotide having the desired sequence to produce a free oligonucleotide have the desired sequence; and a used linker arm; and recycling the used linker arm |
11/14/2006 | US7135563 Screening for nucleotide sequences in sample; obtain sample, incubate with peptide nucleic acid probes, expose to antibodies, detect bound triplex structure, presence of bound triplex indicates presence of preferential nucleotide |
11/14/2006 | US7135562 Avian iFABP gene expression controlling region |
11/14/2006 | US7135561 Infectious bovine viral diarrhea virus clone |
11/14/2006 | US7135560 Vectors; cells; drug targets |
11/14/2006 | US7135559 Proteins and novel genes encoding the same |
11/14/2006 | US7135558 Isolated Drosophila proteins essential for survival nucleic acid molecules encoding essential Drosophila proteins, and uses thereof as insecticidal targets |
11/14/2006 | US7135338 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
11/14/2006 | US7135334 Stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals, including humans. Pharmaceutical compositions are based on polypeptides or antagonists thereto that have been identified for one or more |
11/14/2006 | US7135326 UDP-glucosyltransferases |
11/14/2006 | US7135323 Microbially expressed thermotolerant phytase for animal feed |
11/14/2006 | US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents |
11/14/2006 | US7135320 Adaptor protein FRS2 and related products and methods |
11/14/2006 | US7135318 Modified reductase and its gene |
11/14/2006 | US7135316 Escherichia coli having accession No. PTA 1579 and its use to produce polyhydroxybutyrate |